Vertex To Present at Upcoming Investor Conferences

  Vertex To Present at Upcoming Investor Conferences

Credit Suisse Healthcare Conference 2013

Business Wire

CAMBRIDGE, Mass. -- November 11, 2013

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it will
present at the Credit Suisse Healthcare Conference in Scottsdale, AZ on
Tuesday, November 12 at 1:30 p.m. ET. Vertex will also present at the Deutsche
Bank BioFEST in Boston, MA on December 2 at 2:50 p.m. ET.

The audio portion of the remarks from both conferences will be accessible live
through Vertex’s website at www.vrtx.com in the “Investors” section under the
“Events and Presentations” link. A replay of the conference call and webcast
will be archived on the company’s website for a period of seven days after the
presentations.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop and
commercialize innovative medicines so people with serious diseases can lead
better lives. Vertex scientists and our collaborators are working on new
medicines to cure or significantly advance the treatment of cystic fibrosis,
hepatitis C, rheumatoid arthritis and other life-threatening diseases. In
addition to our clinical development programs, Vertex has more than a dozen
ongoing preclinical programs aimed at other serious and life-threatening
diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development
sites and commercial offices in the United States, Europe, Canada and
Australia. For four years in a row, Science magazine has named Vertex one of
its Top Employers in the life sciences. For additional information and the
latest updates from the company, please visit www.vrtx.com.

(VRTX-WEB)

Contact:

Vertex Pharmaceuticals Incorporated
Investors:
Michael Partridge, 617-341-6108
or
Kelly Lewis, 617-961-7530
 
Press spacebar to pause and continue. Press esc to stop.